2567 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Completed Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
2 Completed Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
3 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
4 Terminated The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Not yet recruiting Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Conditions: Brain Injuries;   Wounds and Injuries;   Hemorrhage
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
7 Recruiting A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes
Conditions: Arterial Calcification;   Diabetes Mellitus Type 2
Interventions: Dietary Supplement: Menaquinone-7;   Dietary Supplement: Placebo
8 Not yet recruiting Efficacy of Aspirin and L-arginine in High Risk Preeclamptic
Condition: High Risk Pregnancy
Interventions: Drug: L-arginine;   Drug: Placebo (for L-arginine);   Drug: acetylsalicylic acid
9 Not yet recruiting 3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation
Condition: Coronary Artery Disease
Interventions: Drug: Aspirin;   Drug: Thienopyridine
10 Not yet recruiting Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy
Condition: Heart Failure
Interventions: Device: HeartMate II (HMII);   Drug: Warfarin;   Drug: acetylsalicylic acid (ASA) therapy
11 Active, not recruiting The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
Condition: Acute ST Elevation Myocardial Infarction
Interventions: Drug: rhTNK-tPA;   Drug: alteplase
12 Not yet recruiting Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Conditions: Rhegmatogenous Retinal Detachment;   High-risk for Proliferative Vitreoretinopathy (PVR)
Interventions: Drug: 5-fluorouracil and low molecular weight heparin;   Drug: Placebo
13 Recruiting Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
Conditions: Aortic Valve Stenosis;   Cardiovascular Diseases;   Heart Valve Diseases;   Ventricular Outflow Obstruction;   Thrombosis
Interventions: Drug: Acetylicsalicylic acid;   Drug: Clopidogrel;   Drug: Rivaroxaban
14 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (20 mg);   Drug: Vitamin K antagonists (VKA)
15 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (15 mg);   Drug: Aspirin
16 Not yet recruiting Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation
Condition: Percutaneous Transluminal Coronary Angioplasty
Interventions: Procedure: QCA and Aspirin;   Procedure: QCA and Clopidogrel;   Procedure: Imaging guided and Aspirin;   Procedure: Imaging guided and Clopidogrel
17 Completed Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty
Condition: Osteoarthritis, Knee
Interventions: Drug: Peri-articular tranexamic acid;   Drug: Intravenous tranexamic acid
18 Not yet recruiting Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)
Condition: Critical Limb Ischemia
Interventions: Drug: Triple antiplatelet therapy (aspirin (100 mg), clopidogrel (75 mg), and cilostazol (200 mg) );   Drug: Dual antiplatelet therapy (aspirin (100 mg) and clopidogrel (75 mg)) using aspirin and clopidogrel;   Drug: Dual antiplatelet therapy (aspirin (100 mg) and cilostazol (200 mg)) using aspirin and cilostazol
19 Recruiting Ulipristal Use in Chinese Population
Condition: Fibroid
Interventions: Drug: Ulipristal acetate;   Other: Placebo pills;   Drug: Ferrous sulphate;   Drug: Tranexamic Acid
20 Not yet recruiting Role of Inflammatory Mediators in AERD
Condition: Asthma, Aspirin-Induced
Intervention: Drug: aspirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years